|
| |
Inovio BiomedicalInovio Biomedical Corporation (AMEX: INO) is a leader in cancer and other medical therapies using electroporation-enabled delivery of useful biopharmaceuticals
Inovio Biomedical Corporation (AMEX: INO) is a late stage biomedical company developing novel therapies enabled by electroporation, with a focus on addressing critical unmet treatment needs in oncology. Clinical results validate its local cancer therapy's ability to preserve healthy tissue while selectively killing cancer cells in solid tumors. Compared to surgery, this treatment is simpler, superior in its ability to preserve tissue structure and function (providing quality of life benefits), and lower cost. Inovio's non-viral delivery platform enabled the first-ever clinical study to deliver a gene in humans using electroporation. With the validation of promising pre-clinical data and licensing agreements with Merck and Vical, the company's technology may be instrumental in achieving the potential of important therapeutic genes and DNA vaccines.
| Contact Details: |
| 11494 Sorrento Valley Rd. |
| San Diego |
| California |
| 92121-1318 |
| United States of America |
| Tel: | 858-597-6006 or 877-446-6846 (877-4-INOVIO) |
| Fax: | 858-597-0451 |
| Email: | new.products@inovio.com |
| WWW: | www.genetronics.com/
|
|
Loading...
|
Recent Publications by Inovio Biomedical: |  |
Electroporation of cytokines for cancer gene therapy.
INTRODUCTION: Circulating tumor cells (CTCs) are detectable in most cancer... | 14th October, 2009
| Inovio Biomedical Corporation, Blue Bell, PA, USA.
| Cancer Biol Ther. 2009 Nov 15;8(22).
|
Enhancement of DNA cancer vaccine efficacy by combination with anti-angiogenesis in regression of established subcutaneous B16 melanoma.
Immunotherapy of cancer offers great promise, however translation into... | 30th September, 2009
| Department of Research and Development, Inovio Biomedical Corporation, San
| Oncol Rep. 2009 Nov;22(5):1197-203.
|
Applicator and electrode design for in vivo DNA delivery by electroporation.
As in vivo electroporation advances from the preclinical phase to clinical... | 6th June, 2008
| Inovio Biomedical Corp., San Diego, CA, USA.
| Methods Mol Biol. 2008;423:35-59.
DOI Direct Link |
[DNA--the future in vaccine technology?]
DNA vaccines represent a new and promising technology that uses DNA to... | 9th December, 2006
| Inovio Biomedical Corporation, 11494 Sorrento Valley Road, San Diego, CA,
| Tidsskr Nor Laegeforen. 2006 Nov 16;126(22):2964-8.
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 358 times since April 2007, the link to the organisation's website has been followed 50 times Recent Search Terms used to find this page: inovio bio | inovio | . Search for more companies in San Diego Search for more companies in California This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Inovio Biomedical |
